Eighth Annual Rennert Lecture Highlights Advances in Osteosarcoma

March 9, 2010

Owen Rennert, MD, guest speaker Richard G. Gorlick, MD, and Lombardi's Jeffrey Toretsky, MD
Owen Rennert, MD, guest speaker Richard G. Gorlick, MD, and Lombardi's Jeffrey Toretsky, MD

The eighth Annual Ian Peter Rennert Lectureship in Pediatric Oncology was held at Lombardi on Friday, March 5th. Richard G. Gorlick, MD, vice chair of Pediatrics and chief of Pediatric Hematology/Oncology at Children’s Hospital of Montefiore Medical Center, was this year’s lecturer.

This lectureship celebrates the life and honors the memory of Ian Peter Rennert, a young man who died of lymphoma during his first year at Harvard University. His parents, Owen Rennert, MD and Sandra Rennert, established this annual lectureship through a generous gift, which allows Lombardi to present an educational opportunity by featuring world-renowned experts in pediatric cancer research and treatment. Owen Rennert is the former Chair of the Department of Pediatrics at Georgetown University Hospital.

Gorlick spoke on the topic of “Osteosarcoma: Its Biology Needs to Define New Treatment” to a large group of students, scientists and clinicians from Georgetown University Medical Center and Georgetown University Hospital. Gorlick is a practicing pediatric oncologist, specializing in the treatment of children, adolescents and young adults with sarcomas. At Montefiore he leads a molecular pharmacology research laboratory focused on studying mechanisms of drug resistance and pathogenesis in osteosarcoma. The Gorlick laboratory serves as a Bone Tumor Resource Laboratory for the Children’s Oncology Group (COG), a role it has served since COG began bone tumor tissue banking in 1998. The lab is also a member of the Pediatric Preclinical Testing Program, screening drugs through osteosarcoma xenografts models.

Author: Allison Whitney